Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).
The global decline in prevalence of lymphatic filariasis has been one of the major successes of the WHO's NTD programme. The recommended strategy of intensive, community-wide mass drug administration, aims to break localised transmission by either reducing the prevalence of microfilaria positiv...
Main Authors: | Benjamin S Collyer, Michael A Irvine, T Deidre Hollingsworth, Mark Bradley, Roy M Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008644 |
Similar Items
-
Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017-03-01) -
Population migration: implications for lymphatic filariasis elimination programmes.
by: K D Ramaiah
Published: (2013-01-01) -
Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
by: Kazuyo Ichimori, et al.
Published: (2014-12-01) -
Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015-03-01) -
Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
by: Kazuyo Ichimori, et al.
Published: (2017-11-01)